Research and Reports in Tropical Medicine is a distinguished open-access journal dedicated to advancing knowledge in the field of tropical medicine. Published by DOVE MEDICAL PRESS LTD, this journal operates under the ISSN 1179-7282, facilitating global access to quality research since its inception in 2010. With a commitment to disseminating innovative findings and critical analyses, the journal serves as a vital platform for researchers, professionals, and students engaged in the diverse aspects of tropical diseases and public health challenges. Research and Reports in Tropical Medicine welcomes original research articles, reviews, and case studies that contribute to an improved understanding of health issues in tropical regions, making it an essential resource for those aiming to impact global health positively.

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

Epidemics, an esteemed journal published by Elsevier, serves as a key resource for scholars and practitioners in the fields of epidemiology, infectious diseases, microbiology, parasitology, and public health. With an impact factor that places it in the Q1 and Q2 categories across various disciplines, the journal has garnered recognition for its rigorous peer-reviewed research, facilitating high-impact findings in the study of the dynamics of infectious diseases and their broader implications on public health. Since becoming an Open Access journal in 2014, Epidemics has significantly enhanced the accessibility of cutting-edge research, empowering a global audience of researchers, professionals, and students to engage with the latest developments in the field. The journal's comprehensive scope allows for the exploration of critical issues in health, analytics, and intervention strategies, making it a vital publication for those dedicated to understanding and combating epidemics in the contemporary landscape.

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

The American Journal of Tropical Medicine and Hygiene, published by the American Society of Tropical Medicine & Hygiene, serves as a pivotal platform for the dissemination of innovative research and clinical findings in the realm of tropical medicine and health. With an illustrious history dating back to 1945, this journal has maintained its commitment to enhancing global health, particularly in the fields of Infectious Diseases, Parasitology, and Virology. It currently boasts an impressive impact factor and ranks in the Q1 category for Parasitology and Q2 for Infectious Diseases and Medicine (miscellaneous), highlighting its academic prominence. The journal's mission is to advance research, showcase cutting-edge studies, and foster collaboration among researchers, healthcare professionals, and students dedicated to tackling tropical diseases and improving public health worldwide. While access is not open, the journal remains a critical resource for anyone looking to stay informed on the latest advancements in the field.

Welcome to Transboundary and Emerging Diseases, a prestigious journal published by WILEY-HINDAWI. With its ISSN of 1865-1674 and E-ISSN of 1865-1682, this journal plays a pivotal role in the dissemination of high-quality research within the fields of Immunology, Microbiology, Medicine, and Veterinary Sciences. Based in the United Kingdom, this open-access journal stands out with a remarkable impact factor, reflecting its category quartiles in 2023, where it secured Q1 rankings across multiple disciplines, including a remarkable rank of #3 out of 194 in Veterinary General, placing it in the top 2% of its field. With coverage spanning from 2008 to 2024, Transboundary and Emerging Diseases provides a vital platform for researchers, professionals, and students to explore emerging threats to global health and animal welfare. The journal's commitment to open access ensures broad availability of cutting-edge research, fostering collaboration and knowledge sharing in pursuit of innovative solutions to transboundary diseases. Join a community dedicated to advancing the science and practice within this crucial area of study.

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.